Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Bacterial Infection”

312 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 312 results

Early research (Phase 1)Study completedNCT05286567
What this trial is testing

Placebo-controlled Randomized Trial Evaluating the Efficacy and Safety of a Novel HSP90 Inhibitor (RGRN-305) in the Treatment of Moderate to Severe Hidradenitis Supppurativa.

Who this might be right for
Hidradenitis Suppurativa
Aarhus University Hospital 15
Post-approval studies (Phase 4)Study completedNCT02767271
What this trial is testing

Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris

Who this might be right for
Tinea PedisTinea Cruris
Bausch Health Americas, Inc. 30
Not applicableStudy completedNCT00001990
What this trial is testing

An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
Glaxo Wellcome
Not applicableStudy completedNCT02888197
What this trial is testing

Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization

Who this might be right for
Candidiasis, VulvovaginalYeast InfectionMycoses+2 more
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 32
Testing effectiveness (Phase 2)Study completedNCT03248531
What this trial is testing

Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.

Who this might be right for
Hidradenitis Suppurativa
UCB Biopharma SRL 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT05139602
What this trial is testing

Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Who this might be right for
Hidradenitis Suppurativa
AbbVie 210
Large-scale testing (Phase 3)Looking for participantsNCT04678154
What this trial is testing

Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2

Who this might be right for
Post Operative Surgical Site Infection
Major Extremity Trauma Research Consortium 600
Testing effectiveness (Phase 2)Study completedNCT00771342
What this trial is testing

Efficacy Study to Evaluate the Effect of Nitric Oxide on the Treatment of Tinea Pedis (Athlete's Foot)

Who this might be right for
Tinea
Nitric BioTherapeutics, Inc 50
Early research (Phase 1)Looking for participantsNCT06888193
What this trial is testing

Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Who this might be right for
Moderate to Severe Plaque PsoriasisPsoriatic ArthritisAxial Spondyloarthritis+1 more
UCB Biopharma SRL 20
Not applicableStudy completedNCT03919812
What this trial is testing

Immunomodulatory Vitamin D in Thalassemia

Who this might be right for
ThalassemiaTuberculosisVitamin D Deficiency
Universitas Padjadjaran 60
Early research (Phase 1)Study completedNCT00001911
What this trial is testing

Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections

Who this might be right for
Atypical Mycobacterium Infection
National Institute of Allergy and Infectious Diseases (NIAID) 10
Post-approval studies (Phase 4)Study completedNCT02285075
What this trial is testing

Temocillin Pharmacokinetic in Hemodialysis

Who this might be right for
Gram-Negative Bacterial InfectionsRenal Failure Chronic Requiring Hemodialysis
AZ Sint-Jan AV 16
Testing effectiveness (Phase 2)Study completedNCT00021567
What this trial is testing

A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections

Who this might be right for
Mycobacterium Avium-Intracellulare Infection
National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Ended earlyNCT01838499
What this trial is testing

Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
AstraZeneca 224
Testing effectiveness (Phase 2)Study completedNCT02216708
What this trial is testing

Slow Versus Rapid Rehydration of Severely Malnourished Children

Who this might be right for
Diarrhea
International Centre for Diarrhoeal Disease Research, Bangladesh 208
Testing effectiveness (Phase 2)Study completedNCT04762277
What this trial is testing

Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
Boehringer Ingelheim 52
Not applicableNot Yet RecruitingNCT07495150
What this trial is testing

Intracalvariosseous Plus Intravenous Antibiotics for Moderate-to-Severe Bacterial Meningitis

Who this might be right for
Blood-Brain BarrierBacterial Meningitis
yilong Wang 86
Large-scale testing (Phase 3)Ended earlyNCT04847921
What this trial is testing

Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient Transition

Who this might be right for
Gram-Positive Bacterial InfectionsGram-Positive BacteraemiaSubstance Use Disorders+1 more
University of Colorado, Denver 11
Large-scale testing (Phase 3)Study completedNCT03713632
What this trial is testing

Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)

Who this might be right for
Hidradenitis Suppurativa
Novartis Pharmaceuticals 545
Testing effectiveness (Phase 2)Active Not RecruitingNCT07228390
What this trial is testing

A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.

Who this might be right for
Hidradenitis Suppurativa
Pfizer 128
Next Page